2L
MED icon

25 LLC’s Medifast MED Stock Holding History

25 LLC’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$464 – 330
2023
Q2 		$464 Buy
+5
New +$445 ﹤0.01% 582

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

25 LLC's MED Position: Q3 2023 in Review

25 LLC sold out of Medifast (MED) in Q3 2023, closing a stake of 5 shares — an estimated $464 sold.

25 LLC first reported a position in MED in Q2 2023 and held it in 1 quarter. The position peaked at $464 in Q2 2023. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

  • 25 LLC reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
  • 25 LLC sold 5 Medifast shares in Q3 2023, an estimated $464.
  • 25 LLC first reported a position in Medifast in Q2 2023 and held it in 1 quarter.
  • 25 LLC's Medifast position peaked at $464 in Q2 2023.
  • 223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.